The relationship between dose, route of administration, and clinical outcomes requires systematic investigation to establish therapeutic ranges and maximize efficacy while minimizing potential risks
we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Known and theoretical concerns BPC-157 considerations: BPC-157 promotes angiogenesis (new blood vessel formation), which supports healing but raises theoretical concerns for anyone with cancer or precancerous conditions
Then, we applied BPC 157 (dissolved in saline, 10.0 g, 10.0 ng, 10 pg/kg b.w.) or saline (5.0 ml/kg) intraperitoneally or intragastrically as follows: (i) prophylactically, immediately after or (ii) therapeutically, after 3 hours elapsed